Literature DB >> 10583932

Immunohistochemical detection of p53 protein could improve the management of some patients with Barrett esophagus and mild histologic alterations.

A Giménez1, L M de Haro, P Parrilla, J Bermejo, M Pérez-Guillermo, M A Ortiz.   

Abstract

OBJECTIVE: To determine the usefulness of p53 immunostaining in identifying the subgroup of patients with Barrett esophagus who may be at increased risk of developing adenocarcinoma of the esophagus.
MATERIALS AND METHODS: Tissue samples of 41 patients with Barrett esophagus and available sequential histologic data were processed for p53 immunostaining. Results from each patient were compared over time, and the results of a subset of patients were compared with each other.
RESULTS: We observed a significant correlation between the percentage of samples with p53 expression and the severity of dysplasia. Moreover, in a subset of patients with mild dysplasia (cases classified as showing indefinite dysplasia), we observed a statistically significant difference in the percentage of p53-positive samples between the group that progressed to more severe dysplasia and the group that did not progress.
CONCLUSION: Our results suggest that this procedure, which is technically simple, economical, and quick, could play a role in the evaluation and follow-up of patients with Barrett esophagus.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10583932     DOI: 10.5858/1999-123-1260-IDOPPC

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  3 in total

1.  Abnormal expression of biomarkers in incompletely ablated Barrett's esophagus.

Authors:  Katerina Dvorak; Lois Ramsey; Claire M Payne; Richard Sampliner; Ronnie Fass; Harris Bernstein; Anil Prasad; Harinder Garewal
Journal:  Ann Surg       Date:  2006-12       Impact factor: 12.969

2.  Aberrant p53 Immunostaining in Barrett's Esophagus Predicts Neoplastic Progression: Systematic Review and Meta-Analyses.

Authors:  Patrick Snyder; Kerry Dunbar; Daisha J Cipher; Rhonda F Souza; Stuart Jon Spechler; Vani J A Konda
Journal:  Dig Dis Sci       Date:  2019-03-26       Impact factor: 3.199

Review 3.  Use of immunohistochemical biomarkers as independent predictor of neoplastic progression in Barrett's oesophagus surveillance: A systematic review and meta-analysis.

Authors:  Vincent T Janmaat; Sophie H van Olphen; Katharina E Biermann; Leendert H J Looijenga; Marco B Bruno; Manon C W Spaander
Journal:  PLoS One       Date:  2017-10-23       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.